Lolatinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lolatinib, covering 2024-05-10 to 2024-05-10. Get the full timeline:
Most recent: Clinical Trial Update: A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis